全文获取类型
收费全文 | 476篇 |
免费 | 17篇 |
国内免费 | 22篇 |
专业分类
儿科学 | 27篇 |
基础医学 | 44篇 |
口腔科学 | 12篇 |
临床医学 | 52篇 |
内科学 | 76篇 |
皮肤病学 | 3篇 |
神经病学 | 1篇 |
特种医学 | 181篇 |
外科学 | 24篇 |
综合类 | 2篇 |
预防医学 | 15篇 |
眼科学 | 7篇 |
药学 | 44篇 |
肿瘤学 | 27篇 |
出版年
2023年 | 1篇 |
2021年 | 4篇 |
2020年 | 1篇 |
2019年 | 1篇 |
2018年 | 5篇 |
2017年 | 1篇 |
2015年 | 3篇 |
2014年 | 2篇 |
2013年 | 10篇 |
2012年 | 2篇 |
2011年 | 5篇 |
2010年 | 11篇 |
2009年 | 10篇 |
2008年 | 10篇 |
2007年 | 22篇 |
2006年 | 9篇 |
2005年 | 13篇 |
2004年 | 6篇 |
2003年 | 4篇 |
2002年 | 1篇 |
2001年 | 9篇 |
2000年 | 6篇 |
1999年 | 3篇 |
1998年 | 32篇 |
1997年 | 44篇 |
1996年 | 25篇 |
1995年 | 27篇 |
1994年 | 19篇 |
1993年 | 12篇 |
1992年 | 3篇 |
1991年 | 8篇 |
1990年 | 10篇 |
1989年 | 19篇 |
1988年 | 25篇 |
1987年 | 16篇 |
1986年 | 18篇 |
1985年 | 22篇 |
1984年 | 10篇 |
1983年 | 8篇 |
1982年 | 16篇 |
1981年 | 7篇 |
1980年 | 15篇 |
1979年 | 6篇 |
1978年 | 7篇 |
1977年 | 8篇 |
1976年 | 14篇 |
1975年 | 4篇 |
1973年 | 1篇 |
排序方式: 共有515条查询结果,搜索用时 578 毫秒
101.
Van Lysel MS; Dobbins JT d; Peppler WW; Hasegawa BH; Lee CS; Mistretta CA; Zarnstorff WC; Crummy AB; Kubal W; Bergsjordet B; Strother CM; Sackett JF 《Radiology》1983,147(3):869-874
Initial clinical results using a digital fluoroscopic implementation of the combined time-energy ("hybrid") subtraction technique are described, with emphasis on carotid and renal imaging. Where patient motion artifacts are due to soft-tissue motion alone, hybrid subtraction can remove them. Due to the need for a finite separation time between high- and low-energy pairs, however, the present implementation of the hybrid technique is not completely immune to soft-tissue motion. The intrinsic signal-to-noise ratio of hybrid imaging is less than that of conventional temporal subtraction. However, since the low-energy temporal subtraction images are included in the hybrid data set, the diagnostic quality of the examination is not compromised. 相似文献
102.
Ton AF Lenssen Mike JA van Steyn Yvonne HF Crijns Eddie MH Waltjé George M Roox Ruud JT Geesink Piet A van den Brandt Rob A De Bie 《BMC musculoskeletal disorders》2008,9(1):60
Background
Adequate and intensive rehabilitation is an important requirement for successful total knee arthroplasty. 相似文献103.
104.
105.
A retrospective study of pretransfusion testing records compared the utility of the antiglobulin test (AGT) phase of the crossmatch and the autologous control (autocontrol) for detecting clinically significant alloimmunization to red cells (RBCs). Of 110,780 consecutive crossmatches, 141 were positive after a negative antibody screening test; only 4 of these were due to alloantibodies of potential clinical significance, for a predictive value of a positive AGT crossmatch, after a negative antibody screen, of 2.8 percent (4/141). The frequency of potentially shortened RBC survival was 1 in 27,685 units crossmatched. During a similar period, 56,090 autocontrols were performed with the antibody screen. The autocontrol was positive on 902 samples in which the antibody screen was negative. Antibody identification performed in 684 cases generally yielded only cold or warm autoagglutinins. In 96 cases, some form of alloantibody was detected, but only 25 had potential clinical significance by our criteria. Eight of these alloantibodies had concurrently caused in vivo sensitization of RBCs and were classified as delayed hemolytic transfusion reactions. The predictive value of the autocontrol, calculated as the number of significant alloantibodies detected in autocontrol-positive, antibody-screen-negative samples, was 3.6 percent (25/684). Inspection of these cases revealed 11 in which shortened RBC survival might have resulted if the serologic abnormality had not been detected. Thus, the autocontrol had a slightly greater yield of clinically significant findings than the AGT crossmatch.(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献
106.
Detecting fetomaternal hemorrhage: a comparison of five methods 总被引:3,自引:0,他引:3
KM Bayliss ; BD Kueck ; ST Johnson ; JT Fueger ; PW McFadden ; D Mikulski ; JL Gottschall 《Transfusion》1991,31(4):303-307
Appropriate postpartum administration of Rh immune globulin relies on sensitive detection and accurate quantitation of fetomaternal hemorrhage (FMH). Recently, the microscopic Du test (micro Du) enhanced with polyethylene glycol (PEG Du) and flow cytometry (FC) have been advocated for this purpose. Three qualitative methods (micro Du, rosette test, and PEG Du) and two quantitative methods (acid elution and FC) for assessing FMH were evaluated with particular attention given to PEG Du and FC. In vitro studies comprised 10 series of dilutions of D+ cord cells in D- adult cells to yield D+ cell concentrations of 0.06, 0.12, 0.25, 0.50, 0.75, 1.0, and 2.0 percent. Additionally, 26 postpartum samples were tested. Of the qualitative techniques, the micro Du test was the least sensitive with 20 percent false-negative results occurring at 0.5 percent fetal cells. The PEG Du test was only slightly more sensitive and offered no clinical advantage. The rosette test was the most sensitive, consistently detecting fetal cells at concentrations of 0.25 percent or greater. FC and acid elution showed similar results, with good correlation obtained between measured and expected quantities of fetal cells (r = 0.99 and 0.96, respectively). One of 26 postpartum samples was positive by all screening techniques; acid elution and FC detected 0.3-percent concentrations of fetal cells and 0.17-percent concentrations of D+ cells, respectively. Although acid elution is a more commonly used method for quantitating FMH, FC offers an acceptable alternative that is capable of analyzing large numbers of cells with objectivity and reproducibility. 相似文献
107.
Wegener's granulomatosis: long-term follow-up of patients treated with pulse cyclophosphamide 总被引:3,自引:1,他引:3
Treatment with daily oral cyclophosphamide (CY) has improved survival in
Wegener's granulomatosis (WG), but is associated with severe and
potentially lethal adverse effects. Less toxic treatment regimens, such as
pulse CY, have been used, but the effect has been questioned. We have
treated 11 patients with WG with pulse CY (15 mg/kg initially every second
week, gradually increasing the pulse interval). After 4.5 yr follow-up and
a total of 501 pulses of CY, one patient died and eight patients (73%) were
in complete remission. Remission was induced in 91% of the patients after a
median period of 3.5 months and relapses were seen in 60%. With the same
treatment protocol, a new complete remission was induced in 75% of those
relapsing. Except for one patient who died, no patient developed end-stage
renal failure. Haemorrhagic cystitis was not observed and no malignancies
recorded. Severe infections were seen in 36%, but none caused by
Pneumocystis carinii. Nausea was the most frequent side-effect, seen in 64%
of the patients. We conclude that treatment with pulse CY every second week
is safe and effective in inducing remission and treating relapses in WG.
The relapse rate seems to be higher than with low-dose oral CY, but the
cumulative dose of CY is less.
相似文献
108.
Association between gelatinase release and increased plasma membrane expression of the Mo1 glycoprotein 总被引:7,自引:0,他引:7
Mo1, a glycoprotein heterodimer (gp 155,95) that functions as an adhesion promoting molecule and as the C3bi receptor of human myeloid cells, is expressed in increased amounts in the plasma membrane after exposure of polymorphonuclear leukocytes (PMNs) to various stimuli. Previous studies have suggested that secondary granules represent an intracellular pool of Mo1 that, upon degranulation, fuse with the plasma membrane resulting in a tenfold increase in surface expression of Mo1. To determine the intracellular location of Mo1, we monitored Mo1 expression by immunofluorescence and compared it to the release of myeloperoxidase (MPO, a marker for the primary granules), vitamin B12 binding protein (B12BP, secondary granules), and gelatinase (gelatinase- containing organelles) following exposure to various stimuli. Human neutrophils stimulated with 20 mmol/L fluoride for 16 minutes exhibited a twofold increase in Mo1 expression and gelatinase release but no enhanced release of primary or secondary granular contents. In a similar fashion, incubation of cells at 37 degrees C for five minutes with 7.5 X 10(-9) to 10(-6) mol/L N-formyl-methionyl-leucyl- phenylalanine (FMLP) resulted in significant increases in both surface Mo1 expression (three- to fivefold) and gelatinase release (five- to eightfold) without significant release of either MPO or B12BP. In addition, both the fluoride and FMLP experiments demonstrated that Mo1 up-modulation alone is not sufficient to activate superoxide (O2-) production. These data indicate that at least one intracellular storage pool of Mo1 is the gelatinase-containing organelles and that their fusion with the plasma membrane results in increased expression of Mo1 on the cell surface. 相似文献
109.
The effect of A02131-1 [3-(5'-hydroxymethyl-2'-furyl)-1-benzyl thieno (3,2-c)pyrazole], a cGMP-specific phosphodiesterase (PDE) inhibitor, on platelet function was investigated. The compound was found to inhibit the aggregation of and adenosine triphosphate (ATP) release from human platelet-rich plasma and washed platelets that were induced by aggregation inducing drugs such as arachidonic acid (AA), collagen, U46619, platelet-activating factor (PAF), adenosine diphosphate (ADP) and A23187, and the inhibitory effect was concentration-dependent. A02131-1 also disaggregated the performed platelet aggregates induced by these inducers. Thromboxane B2 (TXB2) formations caused by collagen, PAF, ADP, and A23187 were inhibited by A02131-1 at concentrations that did not affect the AA-induced formation of TXB2 and prostaglandin D2 (PGD2). A02131-1 suppressed both the generation of inositol 1,4,5- triphosphate (IP3) and the increase of intracellular Ca2+ concentration stimulated by these aggregation inducers. A02131-1 was shown to increase the cAMP and cGMP levels in platelets and the extent was found to be dependent on concentration as well as time. A02131-1 increased the cAMP level much more slowly than the cGMP level. Activities of adenylate cyclase, guanylate cyclase, and PDEs (type I and III) were not altered by A02131-1. However, the activity of cGMP-specific PDE (type V) was inhibited by A02131-1. The antiplatelet aggregation activity and the effect on raising cAMP level of A02131-1 were both potentiated by prostaglandin E1 (PGE1). In the mouse tail bleeding test, A02131-1 was clearly shown to be more effective than dipyridamole in prolonging the tail bleeding time of conscious mice. These data indicate that A02131-1 is a cGMP-specific PDE (type V) inhibitor in human platelets. 相似文献
110.
Hessner MJ; Endean DJ; Casper JT; Horowitz MM; Keever-Taylor CA; Roth M; Flomenberg N; Drobyski WR 《Blood》1995,86(10):3987-3996